MLAB Mesa Laboratories Inc

  1. Stocks
  2. Technology
  3. NASDAQ: MLAB

Price (delayed)

$140.7

Market cap

$752.21M

P/E Ratio

N/A

Dividend/share

$0.64

EPS

-$0.28

Enterprise value

$915.15M

Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries. ...

Highlights
The gross profit has grown by 37% YoY and by 3.1% from the previous quarter
MLAB's revenue is up by 36% year-on-year
Mesa Laboratories's net income has shrunk by 119% YoY but it has surged by 63% QoQ
The company's EPS has shrunk by 119% YoY but it has surged by 63% QoQ
The company's quick ratio fell by 13% YoY and by 8% QoQ
Sector: Technology
Industry: Scientific & Technical Instruments
Website: http://www.mesalabs.com
Peers: TMO HBIO AME MMM

Key stats

What are the main financial stats of MLAB
Market
Shares outstanding
5.35M
Market cap
$752.21M
Enterprise value
$915.15M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.94
Price to sales (P/S)
3.38
EV/EBIT
204.73
EV/EBITDA
23.7
EV/Sales
4.12
Earnings
Revenue
$222.37M
EBIT
$4.47M
EBITDA
$38.62M
Free cash flow
$20.47M
Per share
EPS
-$0.28
Free cash flow per share
$3.83
Book value per share
$72.55
Revenue per share
$41.65
TBVPS
$28.79
Balance sheet
Total assets
$662.98M
Total liabilities
$275.78M
Debt
$189.04M
Equity
$387.21M
Working capital
$72.57M
Liquidity
Debt to equity
0.49
Current ratio
2.74
Quick ratio
1.65
Net debt/EBITDA
4.22
Margins
EBITDA margin
17.4%
Gross margin
61%
Net margin
-0.7%
Operating margin
1.2%
Efficiency
Return on assets
-0.2%
Return on equity
-0.4%
Return on invested capital
1.6%
Return on capital employed
0.7%
Return on sales
2%
Dividend
Dividend yield
0.45%
DPS
$0.64
Payout ratio
N/A

MLAB stock price

How has the Mesa Laboratories stock price performed over time
Intraday
-0.26%
1 week
-11.34%
1 month
-12.6%
1 year
-33.24%
YTD
-15.35%
QTD
-19.48%

Financial performance

How have Mesa Laboratories's revenue and profit performed over time
Revenue
$222.37M
Gross profit
$135.6M
Operating income
$2.69M
Net income
-$1.47M
Gross margin
61%
Net margin
-0.7%
The operating margin has soared by 186% from the previous quarter but it has plunged by 79% YoY
MLAB's operating income has soared by 184% from the previous quarter but it has plunged by 70% YoY
Mesa Laboratories's net income has shrunk by 119% YoY but it has surged by 63% QoQ
The net margin has plunged by 115% YoY but it has soared by 61% from the previous quarter

Growth

What is Mesa Laboratories's growth rate over time

Valuation

What is Mesa Laboratories stock price valuation
P/E
N/A
P/B
1.94
P/S
3.38
EV/EBIT
204.73
EV/EBITDA
23.7
EV/Sales
4.12
The company's EPS has shrunk by 119% YoY but it has surged by 63% QoQ
MLAB's price to book (P/B) is 57% less than its 5-year quarterly average of 4.5 and 25% less than its last 4 quarters average of 2.6
MLAB's equity is up by 3.5% since the previous quarter but it is down by 2.3% year-on-year
The P/S is 59% below the 5-year quarterly average of 8.3 and 32% below the last 4 quarters average of 5.0
MLAB's revenue is up by 36% year-on-year

Efficiency

How efficient is Mesa Laboratories business performance
MLAB's return on equity has dropped by 121% year-on-year but it has surged by 60% since the previous quarter
The return on assets has dropped by 117% year-on-year but it has surged by 67% since the previous quarter
The company's return on sales has shrunk by 76% YoY
Mesa Laboratories's return on invested capital has shrunk by 74% YoY

Dividends

What is MLAB's dividend history
DPS
$0.64
Dividend yield
0.45%
Payout ratio
N/A
Recent dividends

Financial health

How did Mesa Laboratories financials performed over time
Mesa Laboratories's total assets is 140% more than its total liabilities
The total liabilities has contracted by 15% YoY and by 2.2% from the previous quarter
The company's quick ratio fell by 13% YoY and by 8% QoQ
The debt is 51% less than the equity
The debt has contracted by 17% YoY and by 3.9% from the previous quarter
MLAB's debt to equity is down by 16% YoY and by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.